SWOG clinical trial number
CTSU/R1112
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
Closed
Abbreviated Title
R PhIII Sorafenib vs SBRT followed by Sorafenib in Hepatocellular Carcinoma
Status Notes
This protocol is closed to accrual effective 3/10/21.
Activated
06/15/2016
Closed
03/10/2021
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS
Research committees
Gastrointestinal Cancer
Symptom Control and Quality of Life
Treatment
BAY 43-9006
RT
Other Clinical Trials
SWOG Clinical Trial Number
S2205
ICE COMPRESS: Randomized Trial of Limb Cryocompression versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuroropathy
Research Committee(s)
Symptom Control and Quality of Life
Activated
03/16/2023
Accrual
16%
Open
Phase
SWOG Clinical Trial Number
S2010
A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone To Improve Persistence with Endocrine Therapy in Young Women With Stage I-III Breast Cancer (ASPEN)
Research Committee(s)
Symptom Control and Quality of Life
Activated
01/17/2023
Accrual
51%
Open
Phase
SWOG Clinical Trial Number
EAQ202
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Research Committee(s)
Symptom Control and Quality of Life
Activated
10/28/2021
Open
Phase